Interim analysis of afatinib monotherapy in patients with metastatic NSCLC progressing after chemotherapy and erlotinib/gefitinib (E/G) in a trial of afatinib plus paclitaxel versus investigator’s choice chemotherapy following progression on afatinib monotherapy.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Duisburg-Essen, Institut Gustave Roussy, National Taiwan University Hospital, Yonsei University, Yonsei Cancer Hospital, Azienda Ospedaliera San Camillo-Forlanini, Taipei Veterans General Hospital, Shanghai Pulmonary Hospital, Jiangsu Cancer Hospital, Azienda Ospedaliera San Gerardo, Országos Korányi Tbc és Pulmonológiai Intézet, UC Irvine Chao Family Comprehensive Cancer Center, Boehringer Ingelheim (United States), Boehringer Ingelheim (Germany), Samsung Medical Center, Sungkyunkwan University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2600898673